Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Road Walker who wrote (380082)	4/24/2008 1:02:56 PM
From: i-node	Respond to of 1578516

I suspect that most of the funding for that project is coming from government... which funds a large percentage of medical research. So all this profit motive stuff is BS.... Nonsense. I can tell you that several of the medical oncologists I work with have their own research departments which participate in clinical trials of every kind. This is a research cost borne either by the provider or by drug companies, or both. Not by the government. They do this because a cancer treatment is money in the bank for the drug company. NCI (part of NIH) expenditures in 2007 for research on the major cancers were as follows: CA-BREAST $551M CA-COLORECTAL $249M CA-LUNG $262M CA-PROSTATE $306M Total 1.368B. The entire NCI budget for 05 was under 5B. While other agencies also spend money cancer research, NCI is the bulk of it. So all this profit motive stuff is BS.... If you think for a minute that important cancer drugs like NEULASTA ($4,500 for 6mg), GEMCITABINE ($530/gram), or CAMPATH ($850 for 10mg) are developed so the drug companies can soak the government for grant fees, you're nuts. These drugs save lives but are expensive to discover and produce. It isn't grant money they're after. It is PROFITS.